# Coronary Atherosclerosis T1-Weighted Characterization (CATCH)

Study · id `cardio:ct-nct03504956` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03504956](<https://clinicaltrials.gov/study/NCT03504956>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03504956

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 150 participants.

## Technical summary

Registry record NCT03504956. Non-randomized; no masking; primary purpose other. Start 2018-07-30 (actual); primary completion 2027-06-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose other
- Phase: Not applicable
- Enrolled: 150 participants (planned count; ClinicalTrials.gov record NCT03504956, source copy `cardio:ctgov-nct03504956-2026-08-21`, retrieved 2026-10-26)
- Started: 2018-07-30 (actual) (ClinicalTrials.gov record NCT03504956, source copy `cardio:ctgov-nct03504956-2026-08-21`, retrieved 2026-10-26)
- Primary completion: 2027-06-30 (anticipated) (ClinicalTrials.gov record NCT03504956, source copy `cardio:ctgov-nct03504956-2026-08-21`, retrieved 2026-10-26)
- Completion: 2027-12-31 (anticipated) (ClinicalTrials.gov record NCT03504956, source copy `cardio:ctgov-nct03504956-2026-08-21`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT03504956, source copy `cardio:ctgov-nct03504956-2026-08-21`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03504956-2026-08-21`, retrieved 2026-10-26)

## The registry's words

- Brief title: Coronary Atherosclerosis T1-Weighted Characterization (CATCH)
- Acronym: CATCH
- Condition: Coronary Atherosclerosis
- Intervention (Device): Cardiac MRI
- Intervention (Drug): Contrast
- Intervention (Drug): Beta blocker
- Lead sponsor: Cedars-Sinai Medical Center
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Cedars-Sinai Medical Center (`cardio:org-cedars-sinai-medical-center`)

## Provenance

Content hash: 1d928f5641810536815a5672d3c8c4b06d0e62136fe233eaa1df64857d38cebc
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
